DA 5211
Alternative Names: DA-5211Latest Information Update: 15 Dec 2021
At a glance
- Originator Dong-A ST
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 23 Nov 2021 Preclinical trials in Unspecified in South Korea (PO)
- 23 Nov 2021 Dong-A ST plans a phase I trial (In volunteers) in South Korea (NCT05132049)